[1]黄清杰,李茂星,刘 雄△.中医治疗药物性肝损伤研究进展[J].西部中医药,2012,25(07):124-126.
　HUANG Qing-jie,LI Mao-xing,LIU Xiong.Progress of Study on Treatment of Drug-induced Liver Injury with TCM[J].Western Journal of Traditional Chinese Medicine,2012,25(07):124-126.
点击复制

中医治疗药物性肝损伤研究进展
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
25
期数:
2012年07期
页码:
124-126
栏目:
出版日期:
2012-07-15

文章信息/Info

Title:
Progress of Study on Treatment of Drug-induced Liver Injury with TCM
文章编号:
1004-6852(2012)07-0124-03
作者:
黄清杰1，2，李茂星1，3，刘 雄1△
1 甘肃中医学院，甘肃 兰州 730000； 2 甘肃省中医院； 3 兰州军区兰州总医院
Author(s):
HUANG Qing-jie1，2, LI Mao-xing1，3, LIU Xiong1△
1 Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China； 2 Gansu Province Hospital of Traditional Chinese Medcine； 3 Lanzhou General Hospital of Lanzhou Military
关键词:
肝损伤; 药物性; 病因病机; 复方; 活性成分
Keywords:
liver injury;  drug-induced;  causes and pathological mechanism;  compound recipe;  active ingredient
分类号:
R575
文献标志码:
A
摘要:
通过分析相关文献，就现代医学、中医对药物性肝损伤(drug-induced liver injury，DILI)的认识，以及清热解毒利湿类、疏肝理气类、补肾健脾益气养血类、活血化瘀类复方，有机酸类、生物碱类、环烯醚萜类、黄酮苷、多糖等中药活性成分治疗肝损伤的现状进行阐述，旨在指导临床治疗。
Abstract:
Current state is elaborated through analyzing associated literature in order to guide clinical treatment, which involves the cognition of drug-induced liver injury(DILI) in TCM and modern medicine, active ingredient of herbs in treating liver injury. Herbs are of clearing heat, detoxifying and eliminating dampness, soothing liver and regulating Qi, invigorating kidney and spleen, nourishing Qi and blood, activating blood circulation to dissipate blood stasis and active ingredients are of organic acid, alkaloid, iridoid, flavonoid glycoside, polysaccharide and others.

相似文献/References:

[1]孟宪华,陈德道,张樱山,等.藏药“桑蒂”抗肝损伤作用机制研究[J].西部中医药,2014,27(01):135.
　MENG Xianhua,CHEN Dedao,ZHANG Yingshan,et al.Study on the Mechanism of Tibetan Medicine "SangDi" Fighting against Liver Damage[J].Western Journal of Traditional Chinese Medicine,2014,27(07):135.
[2]吕培,何红彦,曹红涛,等.冬虫夏草制剂对抗结核药物致肝肾损伤的“减毒”作用及其机制[J].西部中医药,2020,33(03):16.[doi:10.12174/j.issn.1004-6852.2020.03.05]
　LYU Pei,HE Hongyan,CAO Hongtao,et al.The "Attenuation" Actions and the Mechanism of Dongchong Xiacao Preparation on Liver and Kidney Injury of Antituberculosis Drugs[J].Western Journal of Traditional Chinese Medicine,2020,33(07):16.[doi:10.12174/j.issn.1004-6852.2020.03.05]
[3]李艳,刘丽丽,杨小军,等.慢性乙型肝炎肝郁脾虚证患者中医证候及实验室指标特征观察[J].西部中医药,2022,35(03):72.[doi:10.12174/j.issn.2096-9600.2022.03.17]
　LI Yan,LIU Lili,YANG Xiaojun,et al.Observation on the Characteristics of TCM Syndromes and Lab Indicators of Patients with Chronic Hepatitis B of Liver Depression and Spleen Deficiency Pattern[J].Western Journal of Traditional Chinese Medicine,2022,35(07):72.[doi:10.12174/j.issn.2096-9600.2022.03.17]
[4]吕超,石清兰,覃倩,等.藏、维两族常用保肝药物研究进展[J].西部中医药,2021,34(07):153.[doi:10.12174/j.issn.2096-9600.2021.07.39]
　LYU Chao,SHI Qinglan,QIN Qian,et al.Advances in Research on Common Liver Protective Drugs Used in Tibetan and Uygur[J].Western Journal of Traditional Chinese Medicine,2021,34(07):153.[doi:10.12174/j.issn.2096-9600.2021.07.39]

备注/Memo

备注/Memo:
收稿日期：2012-03-23 作者简介：黄清杰(1979—)，男，在职硕士研究生，主管中药师。研究方向：中药加工炮制。 △通讯作者：刘雄(1964—)，男，硕士研究生导师，教授。研究方向：天然药物化学成分及活性研究。
更新日期/Last Update: 2012-07-15